Advertisement
Product › Details
EX404 (EffRx)
Next higher product group | metformin (INN v) | |
Status | 2013-10-01 development existent | |
Organisation | EffRx Pharmaceuticals S.A. | |
Record changed: 2023-07-10 |
Advertisement
More documents for antidiabetic
- [1] Roche. (12/4/23). "Press Release: Roche Enters into a Definitive Merger Agreement to Acquire Carmot Therapeutics, including Three Clinical Stage Assets with Best-in-class Potential in Obesity and Diabetes". Basel....
- [2] Evolva Holding S.A.. (11/14/23). "Press Release: Evolva and Breko Broaden Partnership by Signing Agreement for the Exclusive Distribution of Veri-te Resveratrol in Germany, Austria, Thailand and Vietnam". Reinach....
- [3] Boehringer Ingelheim. (1/24/23). "Press Release: US FDA Accepts Supplemental New Drug Application for Jardiance for Adults with Chronic Kidney Disease". Ingelheim & Indianapolis, IN....
- [4] Enthera S.r.l.. (1/28/21). "Press Release: Enthera Pharmaceuticals Extends Series A Financing, Raising a Total of €35 million". Milan....
- [5] Hua Medicine (Shanghai) Ltd.. (8/17/20). "Press Release: Bayer and Hua Medicine Announce Commercialization Agreement and Strategic Partnership for Investigational First-in-Class Novel Diabetes Treatment Dorzagliatin in China". Beijing & Shanghai....
- [6] DiogenX. (6/16/20). "Press Release: DiogenX Raises €4.5M in Seed Financing from Advent France Biotechnology, Boehringer Ingelheim Venture Fund and JDRF T1D Fund". Marseille....
- [7] Evotec SE. (4/22/20). "Press Release: Evotec Regains Global Rights to Beta Cell Replacement Therapy". Hamburg....
- [8] Evotec SE. (3/31/20). "Press Release: Evotec and Ildong to Collaborate with Development Projects on INDiGO Platform". Hamburg....
- [9] Boehringer Ingelheim. (12/13/19). "Press Release: Boehringer Ingelheim and Lilly Provide Update on Empagliflozin Phase III Exercise Ability Studies in Chronic Heart Failure". Ingelheim & Indianapolis, IN....
- [10] Boehringer Ingelheim. (11/4/19). "Press Release: Boehringer Ingelheim and Lilly Modernise Alliance to Focus Full Expertise on Jardiance". Ingelheim & Indianapolis, IN....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top